The impact of conflict of interest in abdominal wall reconstruction with acellular dermal matrix

BR DeGeorge Jr, MC Holland… - Annals of Plastic …, 2015 - journals.lww.com
Methods A systematic review of the literature for studies that evaluated surgical outcomes in
abdominal wall reconstruction using ADM was conducted. The level of evidence of these …

Key factors that promote low-value care: views of experts from the United States, Canada, and the Netherlands

EW Verkerk, SA Van Dulmen, K Born… - … Journal of Health …, 2021 - pmc.ncbi.nlm.nih.gov
Background: Around the world, policies and interventions are used to encourage clinicians
to reduce low-value care. In order to facilitate this, we need a better understanding of the …

Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States

M King, PS Bearman - Social Science & Medicine, 2017 - Elsevier
The pharmaceutical industry spends roughly 15 billion dollars annually on detailing–
providing gifts, information, samples, trips, honoraria and other inducements–to physicians …

[图书][B] Physician-industry interactions: Persuasion and welfare

M Grennan, K Myers, A Swanson, A Chatterji - 2018 - faculty.wharton.upenn.edu
In markets where consumers seek expert advice regarding purchases, firms seek to
influence experts, raising concerns about biased advice. Assessing firm-expert interactions …

Trust and transparency: patient perceptions of physicians' financial relationships with pharmaceutical companies

JE Perry, D Cox, AD Cox - Journal of Law, Medicine & Ethics, 2014 - cambridge.org
Financial relationships and business transactions between physicians and the health care
industry are common. These relationships take a variety of forms, including payments to …

The dawn of transparency: insights from the Physician Payment Sunshine Act in plastic surgery

R Ahmed, J Lopez, S Bae, AB Massie… - Annals of plastic …, 2017 - journals.lww.com
Background The Physician Payments Sunshine Act (PSSA) is a government initiative that
requires all biomedical companies to publicly disclose payments to physicians through the …

No free lunch? welfare analysis of firms selling through expert intermediaries

M Grennan, KR Myers, A Swanson… - Review of Economic …, 2024 - academic.oup.com
We study how firms target and influence expert intermediaries. In our context,
pharmaceutical manufacturers provide payments to physicians during promotional …

The basics of the Sunshine Act: how it pertains to the practicing orthopaedic surgeon

TJ Parisi, IM Ferre, HE Rubash - JAAOS-Journal of the American …, 2015 - journals.lww.com
Abstract The Physician Payments Sunshine Act is a disclosure law requiring all drug,
medical device, and biologics companies to report transfers of value to physicians and …

Assessing the impact of the Physician Payments Sunshine Act on pharmaceutical companies' payments to physicians

S Cheng, W Duan, W Zhou - PloS one, 2024 - journals.plos.org
Enacted in 2010 as part of the Affordable Care Act, the Physician Payments Sunshine Act
(PPSA) mandates transparency in financial interactions between pharmaceutical companies …

Selling and sales management

S Misra - Handbook of the Economics of Marketing, 2019 - Elsevier
About 10% of the US labor force is employed in selling related occupations and the
expenditures on selling activities total close to 5% of the US GDP. Without question, selling …